NIH-funded research R01 grant

Oxalate and your immune system in kidney stones

Official title: Oxalate-Driven Host Responses in Kidney Stone Disease

Funded at University of Alabama at Birmingham · NIH-11359754 · Data updated 2026-11-12

This grant looks at how oxalate in our diet affects kidney stone risk and our immune cells, especially in adults with calcium oxalate stones.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startSeptember 1, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$502,545
NIH project number5R01DK129885-05
Project IDNIH-11359754 on NIH RePORTER

Who could benefit from this research

Could help

Adults with a history of calcium oxalate kidney stones or those at risk may be eligible to participate in related components of the study.

Less likely to help

Individuals without kidney stone history or without related immune/monocyte concerns may see no direct benefit.

What this research studies

If you have or are at risk for kidney stones, this project will study how oxalate-rich meals may change tiny crystals in urine and how your immune cells respond. Researchers will use blood samples from adults and model systems to see how monocytes and other immune players react to oxalate and calcium oxalate crystals. They aim to connect dietary oxalate with inflammation and crystal formation to understand why stones recur. The study will combine human data with experimental models to translate findings into potential dietary or therapeutic approaches. Results could help tailor strategies to reduce stone recurrence and improve quality of life.

Why it matters

Potential benefit: If successful, the work could lead to better dietary guidance and new treatments to prevent recurrent kidney stones.

How similar studies have gone: Preliminary work shows oxalate can affect monocyte energetics and inflammation, supporting potential benefits of this approach.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Mitchell, Tanecia R — University of Alabama at Birmingham
  • Study coordinator: Mitchell, Tanecia R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.